Professor Pietiläinen predicts rise in obesity medication use in Finland

A professor of clinical metabolism at the University of Helsinki, obesity specialist Kirsi Pietiläinen, anticipates a significant increase in the use of obesity medications in the future, predicting that there will be many more treatment options available within five years. Recent data from Kela indicates a marked rise in the consumption of obesity medications.

Central to the prescription of these medications is a person’s body mass index (BMI). According to current guidelines, obesity medications can be prescribed for individuals with a BMI over 30, which is categorized as significant, severe, or morbid obesity, depending on the exact number. Additionally, medications may be prescribed to those with a BMI over 27 who also suffer from weight-related health conditions, such as diabetes or high blood pressure. Pietiläinen emphasizes that a thorough assessment by a healthcare provider is necessary to determine the potential benefits for each patient.

In Finland, four obesity medications improve feelings of fullness and help manage appetite, alongside orlistat, a drug that inhibits fat absorption. Pietiläinen advocates for a comprehensive approach combining medication with lifestyle counseling and long-term follow-up to evaluate the effectiveness of the treatment proper.

Pietiläinen notes that the current Finnish healthcare system lacks widespread structures for lifestyle coaching, which is crucial for effective treatment of obesity. Most obesity medications are intended for individuals aged 18 and older, and while they can present side effects such as nausea and digestive issues, serious complications, though rare, are possible.

Furthermore, due to the long-term nature of obesity treatment, the financial burden of these medications—often borne by patients—poses equality issues, with only limited reimbursement available under specific criteria. There’s concern that the popularity of these drugs could lead to misuse for aesthetic purposes rather than genuine health needs.